Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
Related Posts
With Aid Cutoff, Trump Severs a Lifeline for Millions
Shock and grief rippled through the health community as lifelines for care were abruptly severed.
Amid Tension Around H.H.S. Cuts, Kennedy Meets With Tribal Leader
The health secretary’s appearance at a tribal self-governance conference brought collegial discussions and a bit of friction.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Lars Fruergaard Jorgensen has a problem: Too many people want what he’s selling. Mr. Jorgensen is the chief executive of…